Review



mouse anti alpha tubulin  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech mouse anti alpha tubulin
    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. <t>α-tubulin</t> was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Mouse Anti Alpha Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 2889 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti alpha tubulin/product/Proteintech
    Average 96 stars, based on 2889 article reviews
    mouse anti alpha tubulin - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "Activation of the integrated stress response contributes to developmental delay and seizures caused by mitochondrial prolyl-tRNA synthetase (PARS2) deficiency"

    Article Title: Activation of the integrated stress response contributes to developmental delay and seizures caused by mitochondrial prolyl-tRNA synthetase (PARS2) deficiency

    Journal: Redox Biology

    doi: 10.1016/j.redox.2025.103966

    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. α-tubulin was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Figure Legend Snippet: Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. α-tubulin was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.

    Techniques Used: Western Blot, Control, Knockdown, Staining

    PARS2 V95I mutation causes mitochondrial dysfunction and ISR activation in human cells (A) Western blot analysis of ectopically expressed PARS2 proteins. Lysates from HEK-293T cells transfected with plasmids encoding His-tagged wild-type (WT) or the indicated PARS2 variants were immunoblotted with an anti-His antibody. α-actin was used as a loading control. (B) Quantification of the Western blots shown in A. N = 5, ∗∗p < 0.01, ∗∗∗p < 0.001. (C) Western blot analysis of endogenous PARS2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 4, ∗∗∗p < 0.001. (E) Western blot analysis of mtDNA-encoded CO2 and ATP8 and nuclear-DNA encoded NDUFS1, NDUFS3, UQCRFS1 and ATP5A in protein extracts from the wild-type controls and the PARS2 V95I cells. VDAC was used as a loading control. (F) Quantification of the Western blots shown in E. MT-CO2, MT-ATP8, NDUFS1, NDUFS3, and ATP5A, N = 4; UQCRFS1, N = 7. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, ns, not significant. (G) CI, CII and CIV in-gel activity analysis of isolated mitochondria from the wild-type controls and the PARS2 V95I cells. (H) Western blot analysis of P-eIF2α and eIF2α in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (I) Quantification of the Western blots shown in H. N = 5, ∗∗∗∗p < 0.0001. (J) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as the loading control. (K) Quantification of the Western blots shown in J. N = 4. ∗∗∗∗p < 0.0001. (L) Western blot analysis of ATF4 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (M) Quantification of the Western blots shown in L. N = 5, ∗∗∗p < 0.001. (N) Western blot analysis of P-GCN2 and GCN2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (O) Quantification of the Western blots shown in N. N = 4, ∗∗p < 0.01. (P) Western blot analysis of P-PERK and PERK in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (Q) Quantification of the Western blots shown in P. N = 5, ns, not significant.
    Figure Legend Snippet: PARS2 V95I mutation causes mitochondrial dysfunction and ISR activation in human cells (A) Western blot analysis of ectopically expressed PARS2 proteins. Lysates from HEK-293T cells transfected with plasmids encoding His-tagged wild-type (WT) or the indicated PARS2 variants were immunoblotted with an anti-His antibody. α-actin was used as a loading control. (B) Quantification of the Western blots shown in A. N = 5, ∗∗p < 0.01, ∗∗∗p < 0.001. (C) Western blot analysis of endogenous PARS2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 4, ∗∗∗p < 0.001. (E) Western blot analysis of mtDNA-encoded CO2 and ATP8 and nuclear-DNA encoded NDUFS1, NDUFS3, UQCRFS1 and ATP5A in protein extracts from the wild-type controls and the PARS2 V95I cells. VDAC was used as a loading control. (F) Quantification of the Western blots shown in E. MT-CO2, MT-ATP8, NDUFS1, NDUFS3, and ATP5A, N = 4; UQCRFS1, N = 7. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, ns, not significant. (G) CI, CII and CIV in-gel activity analysis of isolated mitochondria from the wild-type controls and the PARS2 V95I cells. (H) Western blot analysis of P-eIF2α and eIF2α in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (I) Quantification of the Western blots shown in H. N = 5, ∗∗∗∗p < 0.0001. (J) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as the loading control. (K) Quantification of the Western blots shown in J. N = 4. ∗∗∗∗p < 0.0001. (L) Western blot analysis of ATF4 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (M) Quantification of the Western blots shown in L. N = 5, ∗∗∗p < 0.001. (N) Western blot analysis of P-GCN2 and GCN2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (O) Quantification of the Western blots shown in N. N = 4, ∗∗p < 0.01. (P) Western blot analysis of P-PERK and PERK in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (Q) Quantification of the Western blots shown in P. N = 5, ns, not significant.

    Techniques Used: Mutagenesis, Activation Assay, Western Blot, Transfection, Control, Activity Assay, Isolation, Staining



    Similar Products

    99
    Developmental Studies Hybridoma Bank mouse anti tubulinβ
    Mouse Anti Tubulinβ, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti tubulinβ/product/Developmental Studies Hybridoma Bank
    Average 99 stars, based on 1 article reviews
    mouse anti tubulinβ - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    LI-COR mouse anti α tubulin
    Mouse Anti α Tubulin, supplied by LI-COR, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti α tubulin/product/LI-COR
    Average 96 stars, based on 1 article reviews
    mouse anti α tubulin - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Proteintech mouse anti alpha tubulin
    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. <t>α-tubulin</t> was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Mouse Anti Alpha Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti alpha tubulin/product/Proteintech
    Average 96 stars, based on 1 article reviews
    mouse anti alpha tubulin - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    Developmental Studies Hybridoma Bank mouse monoclonal anti β tubulin
    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. <t>α-tubulin</t> was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Mouse Monoclonal Anti β Tubulin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti β tubulin/product/Developmental Studies Hybridoma Bank
    Average 99 stars, based on 1 article reviews
    mouse monoclonal anti β tubulin - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Developmental Studies Hybridoma Bank mouse anti tubulin
    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. <t>α-tubulin</t> was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Mouse Anti Tubulin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti tubulin/product/Developmental Studies Hybridoma Bank
    Average 99 stars, based on 1 article reviews
    mouse anti tubulin - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    LI-COR li cor rrid ab 621843 anti acetylated alpha tubulin antibody
    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. <t>α-tubulin</t> was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Li Cor Rrid Ab 621843 Anti Acetylated Alpha Tubulin Antibody, supplied by LI-COR, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/li cor rrid ab 621843 anti acetylated alpha tubulin antibody/product/LI-COR
    Average 96 stars, based on 1 article reviews
    li cor rrid ab 621843 anti acetylated alpha tubulin antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    Developmental Studies Hybridoma Bank mouse anti β tubulin
    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. <t>α-tubulin</t> was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Mouse Anti β Tubulin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti β tubulin/product/Developmental Studies Hybridoma Bank
    Average 99 stars, based on 1 article reviews
    mouse anti β tubulin - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Developmental Studies Hybridoma Bank mouse anti α tubulin
    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. <t>α-tubulin</t> was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.
    Mouse Anti α Tubulin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti α tubulin/product/Developmental Studies Hybridoma Bank
    Average 99 stars, based on 1 article reviews
    mouse anti α tubulin - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. α-tubulin was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.

    Journal: Redox Biology

    Article Title: Activation of the integrated stress response contributes to developmental delay and seizures caused by mitochondrial prolyl-tRNA synthetase (PARS2) deficiency

    doi: 10.1016/j.redox.2025.103966

    Figure Lengend Snippet: Genetic suppression of GCN2 reverses developmental delay and seizure phenotypes in dPARS2-deficient flies. (A) Western blot analysis of P-GCN2, GCN2 and P-PERK in protein extracts from control and elav- Gal4-driven dPARS2 knockdown fly heads. α-tubulin was used as a loading control. (B) Quantification of the Western blots shown in A. P-GCN2, N = 3; GCN2 and P-PERK, N = 4. ∗∗p < 0.01, ns, not significant. (C) Western blot analysis of P-eIF2α in protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown fly heads. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 3. ∗p < 0.05, ∗∗p < 0.01. (E) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown fly heads. Flies were fed with puromycin. α-actin was used as the loading control. (F) Quantification of the Western blots shown in E. N = 3, ∗p < 0.05, ∗∗∗p < 0.001. (G) Images of control, elav -Gal4-driven dPARS2 knockdown and elav -Gal4-driven dPARS2 and GCN2 double knockdown flies at different developmental stages. Scale bars: 500 μm. (H) Graph showing pupariation rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown larvae. N = 3, n = 28–30. (I) Graph showing eclosion rate of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown, and elav -Gal4-driven GCN2 knockdown pupae. N = 3, n = 28–30. (J) Graph showing percentage of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies displaying Bang-sensitive paralytic phenotypes. N = 3, n = 10 sample. ∗∗∗∗p < 0.0001. (K) Graph showing the recovery time of control, elav -Gal4-driven dPARS2 knockdown, elav -Gal4-driven dPARS2 and GCN2 double knockdown and elav -Gal4-driven GCN2 knockdown flies from paralysis. n = 30. ∗∗∗∗p < 0.0001.

    Article Snippet: Mouse anti-Alpha tubulin , Proteintech , 66031-1-Ig.

    Techniques: Western Blot, Control, Knockdown, Staining

    PARS2 V95I mutation causes mitochondrial dysfunction and ISR activation in human cells (A) Western blot analysis of ectopically expressed PARS2 proteins. Lysates from HEK-293T cells transfected with plasmids encoding His-tagged wild-type (WT) or the indicated PARS2 variants were immunoblotted with an anti-His antibody. α-actin was used as a loading control. (B) Quantification of the Western blots shown in A. N = 5, ∗∗p < 0.01, ∗∗∗p < 0.001. (C) Western blot analysis of endogenous PARS2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 4, ∗∗∗p < 0.001. (E) Western blot analysis of mtDNA-encoded CO2 and ATP8 and nuclear-DNA encoded NDUFS1, NDUFS3, UQCRFS1 and ATP5A in protein extracts from the wild-type controls and the PARS2 V95I cells. VDAC was used as a loading control. (F) Quantification of the Western blots shown in E. MT-CO2, MT-ATP8, NDUFS1, NDUFS3, and ATP5A, N = 4; UQCRFS1, N = 7. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, ns, not significant. (G) CI, CII and CIV in-gel activity analysis of isolated mitochondria from the wild-type controls and the PARS2 V95I cells. (H) Western blot analysis of P-eIF2α and eIF2α in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (I) Quantification of the Western blots shown in H. N = 5, ∗∗∗∗p < 0.0001. (J) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as the loading control. (K) Quantification of the Western blots shown in J. N = 4. ∗∗∗∗p < 0.0001. (L) Western blot analysis of ATF4 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (M) Quantification of the Western blots shown in L. N = 5, ∗∗∗p < 0.001. (N) Western blot analysis of P-GCN2 and GCN2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (O) Quantification of the Western blots shown in N. N = 4, ∗∗p < 0.01. (P) Western blot analysis of P-PERK and PERK in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (Q) Quantification of the Western blots shown in P. N = 5, ns, not significant.

    Journal: Redox Biology

    Article Title: Activation of the integrated stress response contributes to developmental delay and seizures caused by mitochondrial prolyl-tRNA synthetase (PARS2) deficiency

    doi: 10.1016/j.redox.2025.103966

    Figure Lengend Snippet: PARS2 V95I mutation causes mitochondrial dysfunction and ISR activation in human cells (A) Western blot analysis of ectopically expressed PARS2 proteins. Lysates from HEK-293T cells transfected with plasmids encoding His-tagged wild-type (WT) or the indicated PARS2 variants were immunoblotted with an anti-His antibody. α-actin was used as a loading control. (B) Quantification of the Western blots shown in A. N = 5, ∗∗p < 0.01, ∗∗∗p < 0.001. (C) Western blot analysis of endogenous PARS2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (D) Quantification of the Western blots shown in C. N = 4, ∗∗∗p < 0.001. (E) Western blot analysis of mtDNA-encoded CO2 and ATP8 and nuclear-DNA encoded NDUFS1, NDUFS3, UQCRFS1 and ATP5A in protein extracts from the wild-type controls and the PARS2 V95I cells. VDAC was used as a loading control. (F) Quantification of the Western blots shown in E. MT-CO2, MT-ATP8, NDUFS1, NDUFS3, and ATP5A, N = 4; UQCRFS1, N = 7. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, ns, not significant. (G) CI, CII and CIV in-gel activity analysis of isolated mitochondria from the wild-type controls and the PARS2 V95I cells. (H) Western blot analysis of P-eIF2α and eIF2α in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (I) Quantification of the Western blots shown in H. N = 5, ∗∗∗∗p < 0.0001. (J) Western blot analysis with anti-puromycin antibody and ponceau staining on protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as the loading control. (K) Quantification of the Western blots shown in J. N = 4. ∗∗∗∗p < 0.0001. (L) Western blot analysis of ATF4 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-actin was used as a loading control. (M) Quantification of the Western blots shown in L. N = 5, ∗∗∗p < 0.001. (N) Western blot analysis of P-GCN2 and GCN2 in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (O) Quantification of the Western blots shown in N. N = 4, ∗∗p < 0.01. (P) Western blot analysis of P-PERK and PERK in protein extracts from the wild-type controls and the PARS2 V95I cells. α-tubulin was used as a loading control. (Q) Quantification of the Western blots shown in P. N = 5, ns, not significant.

    Article Snippet: Mouse anti-Alpha tubulin , Proteintech , 66031-1-Ig.

    Techniques: Mutagenesis, Activation Assay, Western Blot, Transfection, Control, Activity Assay, Isolation, Staining